Can Lifestyle Interventions Combined with a Diabetes Drug Prevent Cognitive Decline?
ALZ Discovery
by
1y ago
Alzheimer’s Drug Discovery Foundation Funds Second Phase of Global Alzheimer’s Prevention FINGER TRIAL ..read more
Visit website
2020 Year in Review: A Defining Time
ALZ Discovery
by
1y ago
This year tested us like no other, but from great challenges came innovation and creativity as we drove forward our mission to identify new therapies to prevent and treat Alzheimer’s disease ..read more
Visit website
ADDF Puts Approval of Newly FDA-Approved Alzheimer’s Drug in Context
ALZ Discovery
by
1y ago
The FDA made a landmark decision on June 7, approving aducanumab (Aduhelm™, Biogen) for the treatment of Alzheimer’s disease. Aducanumab is the first new Alzheimer’s treatment in 17 years and the first ever shown to modify the course of the disease ..read more
Visit website
ADDF Fosters Collaboration, Shares Expertise at CTAD 2020
ALZ Discovery
by
1y ago
The ADDF scientific affairs team and I recently participated in the 13th Clinical Trials on Alzheimer’s Disease (CTAD) conference ..read more
Visit website
A Conversation with the Scientists: Two Phase 2 Trials Exploring Novel Targets
ALZ Discovery
by
1y ago
I sat down with two outstanding ADDF-funded researchers recently to talk about the latest news on their cutting-edge work, the inspiration for their ideas, and when we can expect results from their latest trials.  ..read more
Visit website
The Vital Role of Patients in Alzheimer’s Research
ALZ Discovery
by
1y ago
Robust Alzheimer’s Clinical Trial Portfolio Provides More Opportunities for Patient Participation ..read more
Visit website
A Conversation with Our ADDF-Harrington Scholars: Studying Drug Candidates to Restore Brain Function in Alzheimer’s Patients
ALZ Discovery
by
1y ago
Earlier this year, two outstanding researchers, Paul Fish, Ph.D., and Paul Worley, M.D., were selected by the ADDF and Harrington Discovery Institute to receive ADDF-Harrington Scholar Awards ..read more
Visit website
ADDF’s 22nd International Conference on Alzheimer’s Drug Discovery Pushes for Better Clinical Trials and Highlights the Importance of Biomarkers
ALZ Discovery
by
1y ago
22nd International Conference on Alzheimer’s Drug Discovery ..read more
Visit website
2021 and Beyond: Research Forges Beyond Aduhelm with More Drug Approvals Expected from Diverse and Promising Pipeline
ALZ Discovery
by
1y ago
The FDA approved aducanumab (Aduhelm®), an antibody that clears amyloid plaques from the brain, in June.  ..read more
Visit website

Follow ALZ Discovery on FeedSpot

Continue with Google
Continue with Apple
OR